Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT03195582

The Effect of Chlorohexidine Gel on Tissue Healing Following Surgical Exposure of Dental Implants

Sponsor: Rambam Health Care Campus

Interventions Corsodyl

Updated 6 times since 2017 Last updated: Jun 21, 2017 Started: Aug 31, 2017 Primary completion: Aug 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Bone Loss and Implant Infection and is currently ongoing. Rambam Health Care Campus leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jul 2019 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Jul 2019 [monthly]

Not Yet Recruiting PHASE1_PHASE2

▶ Show 1 earlier version

Jul 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rambam Health Care Campus

Data source: Rambam Health Care Campus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.